You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: RE36247


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE36247
Title: Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
Abstract:A method of hormonally treating menopausal (including perimenopausal and post-menopausal) disorders in women, a composition, and a multi-preparation pack therefor. The administrative regimen to which the pack is particularly adapted comprises continuously and uninterruptedly administering a progestogen to a woman while cyclically administering an estrogen by using a repetitive dosage regimen. This regimen calls for administering the estrogen continuously for a period of time between about 20 and about 120 days, followed by terminating administering the estrogen for a period of time between about 3 and about 7 days. Alternatively, both the progestogen and estrogen may be administered for the full treatment period without interruption. The regimen avoids many of the problems associated with the administration of estrogen alone or with progestogen administered according to conventional regimens, and also avoids problems associated with such conventional regimens by maintaining the estrogen and progestogen at low daily dosage levels of between 0.005 mg and 2.5 mg estrogen and 0.25 mg and 30 mg progestogen.
Inventor(s): Plunkett; Earl E. (London, CA), Wolfe; Bernard M. J. (London, CA)
Assignee: WOCO Investments, Ltd. (CA) Pre JAY Holdings, Limited (CA)
Application Number:08/542,941
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent RE36247
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using the Example of U.S. Patent RE36247

Introduction

When analyzing the scope and claims of a U.S. patent, it is crucial to understand the intricacies of patent law, the process of determining inventorship, and the tools available for patent analytics. This article will delve into these aspects using the example of U.S. Patent RE36247, although the specific details of this patent are not provided here, the general principles and methods can be applied broadly.

Understanding Patent Claims

Patent claims are the most critical part of a patent application as they define the scope of the invention and what is protected by the patent[3].

Definition of Claims

Claims are statements that define the invention and distinguish it from prior art. They must be clear, concise, and supported by the patent specification. Each claim must be presumed valid independently of the validity of other claims[5].

Types of Claims

  • Independent Claims: These claims stand alone and do not refer to any other claims.
  • Dependent Claims: These claims refer back to and further limit another claim.
  • Multiple Dependent Claims: These claims refer back to more than one claim.

Determining Inventorship

Inventorship is a critical aspect of patent law, focusing on who conceived the idea or ideas of the patent claims.

Conception in Patent Law

Conception is defined as the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention. This idea must be sufficient to permit one with ordinary skill in the field to reduce it to practice without undue experimentation[1].

Identifying Inventors

  • An inventor is someone who conceives the subject matter of at least one claim of the patent.
  • Collaborative efforts by two or more persons can also result in joint inventorship.
  • However, reducing an invention to practice by exercising ordinary skill or performing experiments is not sufficient to qualify as an inventor[1].

Patent Analytics and Landscape

Patent analytics is essential for understanding the patent landscape and managing intellectual property effectively.

Claim Coverage Matrix

A Claim Coverage Matrix helps in identifying which patents and claims are actively protecting your intellectual property. It categorizes patents by claims and overarching scope concepts, making it easier to filter, search, and analyze large numbers of patent claims[3].

Scope Concepts

Scope concepts link claims on similar patents, providing a powerful categorization tool. These concepts can be categorized as high-value (current importance), medium-value (potential future direction), or low-value (not worth maintaining)[3].

Claim Charts

Interactive claim charts generated by software like ClaimScape® facilitate the review of patent coverage with engineers, scientists, and management. These charts help in identifying gaps in current coverage and highlighting future design opportunities[3].

Validity and Enforcement of Patents

The validity and enforceability of a patent are crucial for its effectiveness.

Presumption of Validity

Each claim of a patent is presumed valid independently of the validity of other claims. However, this presumption can be challenged through various defenses, such as obviousness, lack of written description, or deceptive intent in naming inventors[5].

Obviousness-Type Double Patenting

This doctrine invalidates claims that are not patentably distinct from earlier claims. For example, in the case of Allergan USA, Inc. v. MSN Laboratories Private Ltd., the court determined that claims were invalid due to obviousness-type double patenting if they were not distinct from earlier-filed claims[2].

Deceptive Intent

Errors in inventorship, especially those made with deceptive intent, can render a patent unenforceable. Correcting inventorship errors after a patent is issued does not rectify the issue if the original application was fraudulent[1].

Probability of Receiving a U.S. Patent

Understanding the probability of receiving a U.S. patent can help in strategizing the patent application process.

Allowance Rates

The probability of a patent being allowed can be estimated through various measures such as first-action allowance rate, progenitor allowance rate, and family allowance rate. These rates vary based on factors like the technology field and the use of continuation procedures[4].

Continuation Procedures

Continuation procedures, such as Requests for Continued Examination (RCEs) and continuations-in-part, can significantly impact the outcome of a patent application. These procedures allow applicants to address rejections and introduce new subject matter, complicating the calculation of allowance rates[4].

Key Takeaways

  • Claims Definition: Claims are critical in defining the scope of the invention and must be clear, concise, and supported by the patent specification.
  • Inventorship: Conception is key in determining inventorship, and only those who conceive the idea or ideas of the patent claims qualify as inventors.
  • Patent Analytics: Tools like Claim Coverage Matrix and Claim Charts are essential for managing and analyzing patent claims effectively.
  • Validity and Enforcement: Patents are presumed valid, but challenges such as obviousness-type double patenting and deceptive intent can affect their enforceability.
  • Probability of Allowance: Understanding allowance rates and continuation procedures can help in strategizing the patent application process.

FAQs

Q1: What is the significance of claims in a patent application? Claims define the scope of the invention and distinguish it from prior art, making them the most critical part of a patent application.

Q2: How is inventorship determined in patent law? Inventorship is determined by identifying who conceived the subject matter of at least one claim of the patent, focusing on the conception step rather than the reduction to practice.

Q3: What is patent analytics, and how does it help in managing intellectual property? Patent analytics involves tools like Claim Coverage Matrix and Claim Charts to categorize and analyze patent claims, helping in identifying gaps and opportunities in intellectual property protection.

Q4: What is obviousness-type double patenting, and how does it affect patent validity? Obviousness-type double patenting invalidates claims that are not patentably distinct from earlier claims, making them invalid if they do not meet the criteria for distinctiveness.

Q5: How do continuation procedures impact the patent application process? Continuation procedures allow applicants to address rejections and introduce new subject matter, which can complicate the calculation of allowance rates but provide opportunities to refine and expand the patent application.

Sources

  1. Determination of proper inventorship for US Patent Applications - Oregon State University
  2. Allergan USA, Inc. v. MSN Laboratories Private Ltd. - United States Court of Appeals for the Federal Circuit
  3. Patent Analytics - Schwegman, Lundberg & Woessner, P.A.
  4. What Is the Probability of Receiving a US Patent? - Yale Journal of Law and Technology
  5. 35 USC 282: Presumption of validity; defenses - U.S. House of Representatives

More… ↓

⤷  Subscribe


Drugs Protected by US Patent RE36247

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent RE36247

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0136011 ⤷  Subscribe C00136011/03 Switzerland ⤷  Subscribe
European Patent Office 0136011 ⤷  Subscribe SPC/GB00/025 United Kingdom ⤷  Subscribe
European Patent Office 0136011 ⤷  Subscribe SPC/GB02/008 United Kingdom ⤷  Subscribe
European Patent Office 0136011 ⤷  Subscribe SPC/GB97/032 United Kingdom ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.